Use access key #2 to skip to page content.
$67.11 0.22 (0.33%)
10/7/2008 11:21 AM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
**

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar csmith201 (98.13) Submitted: 4/20/07 3:20 PM : Outperform Start Price: $41.85 IMCL Score: 89.48

Good pipline...Waiting on PIII of Erbitux

Report this Post Replies: 0 | Reply

Featured Broker Partners